These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35745507)

  • 21. Assessment of chitosan nanoparticles in improving the efficacy of nitazoxanide on cryptosporidiosis in immunosuppressed and immunocompetent murine models.
    Moawad HSF; Hegab MHAE; Badawey MSR; Ashoush SE; Ibrahim SM; Ali AAES
    J Parasit Dis; 2021 Sep; 45(3):606-619. PubMed ID: 34475640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ASSESSING THE EFFICACY OF NITAZOXANIDE IN TREATMENT OF CRYPTOSPORIDIOSIS USING PCR EXAMINATION.
    Abaza BE; Hamza RS; Farag TI; Abdel-Hamid MA; Moustafa RA
    J Egypt Soc Parasitol; 2016 Dec; 46(3):683-692. PubMed ID: 30230765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitazoxanide for cryptosporidial diarrhea.
    Bowers M
    BETA; 1998 Apr; ():30-1. PubMed ID: 11365264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.
    Moustafa MA
    J Egypt Soc Parasitol; 2003 Aug; 33(2):443-56. PubMed ID: 14964659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Cytopathic Effect-Based Phenotypic Screening Assay against Cryptosporidium.
    Chao AT; Lee BH; Wan KF; Selva J; Zou B; Gedeck P; Beer DJ; Diagana TT; Bonamy GMC; Manjunatha UH
    ACS Infect Dis; 2018 Apr; 4(4):635-645. PubMed ID: 29341586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nitazoxanide on cryptosporidiosis in experimentally infected neonatal dairy calves.
    Ollivett TL; Nydam DV; Bowman DD; Zambriski JA; Bellosa ML; Linden TC; Divers TJ
    J Dairy Sci; 2009 Apr; 92(4):1643-8. PubMed ID: 19307646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.
    Lee S; Harwood M; Girouard D; Meyers MJ; Campbell MA; Beamer G; Tzipori S
    PLoS One; 2017; 12(10):e0185906. PubMed ID: 28973041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host cells with transient overexpression of MDR1 as a novel in vitro model for evaluating on-target effect for activity against the epicellular Cryptosporidium parasite.
    Yang B; Wang D; Liu M; Wu X; Yin J; Zhu G
    J Antimicrob Chemother; 2021 Dec; 77(1):124-134. PubMed ID: 34648615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocompetent rabbits infected with Cryptosporidium cuniculus as an animal model for anti-cryptosporidial drug testing.
    Lu C; Liu X; Liu J; Tang X; Zhu G; Striepen B; Suo X
    Int J Parasitol; 2022 Mar; 52(4):205-210. PubMed ID: 34774541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nullscript inhibits Cryptosporidium and Toxoplasma growth.
    Murakoshi F; Bando H; Sugi T; Adeyemi OS; Nonaka M; Nakaya T; Kato K
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():159-166. PubMed ID: 33120250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining Stage-Specific Activity of Potent New Inhibitors of Cryptosporidium parvum Growth
    Funkhouser-Jones LJ; Ravindran S; Sibley LD
    mBio; 2020 Mar; 11(2):. PubMed ID: 32127445
    [No Abstract]   [Full Text] [Related]  

  • 32. Garlic (Allium sativum Linnaeus) improved inflammation and reduced cryptosporidiosis burden in immunocompromised mice.
    Farid A; Yousry M; Safwat G
    J Ethnopharmacol; 2022 Jun; 292():115174. PubMed ID: 35259443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiparasitic and immunomodulating effects of nitazoxanide, ivermectin and selenium on Cryptosporidium infection in diabetic mice.
    Fahmy MA; Abdelaal AA; Hassan SI; Shalaby MA; Ismail MAM; Khairy RA; Badawi MA; Afife AA; Fadl HO
    Rev Bras Parasitol Vet; 2021; 30(4):e012121. PubMed ID: 34852131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls
    Swale C; Bougdour A; Gnahoui-David A; Tottey J; Georgeault S; Laurent F; Palencia A; Hakimi MA
    Sci Transl Med; 2019 Nov; 11(517):. PubMed ID: 31694928
    [No Abstract]   [Full Text] [Related]  

  • 36. Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases.
    Guo F; Zhang H; Fritzler JM; Rider SD; Xiang L; McNair NN; Mead JR; Zhu G
    J Infect Dis; 2014 Apr; 209(8):1279-87. PubMed ID: 24273180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Cryptosporidial Drug-Discovery Challenges and Existing Therapeutic Avenues: A "One-Health" Concern.
    Ali M; Xu C; Nawaz S; Ahmed AE; Hina Q; Li K
    Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38255695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptotic changes in the intestinal epithelium of
    Hassan ZR; Salama DEA; Ibrahim HF
    J Parasit Dis; 2022 Dec; 46(4):1011-1020. PubMed ID: 36457780
    [No Abstract]   [Full Text] [Related]  

  • 39. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection.
    Ndao M; Nath-Chowdhury M; Sajid M; Marcus V; Mashiyama ST; Sakanari J; Chow E; Mackey Z; Land KM; Jacobson MP; Kalyanaraman C; McKerrow JH; Arrowood MJ; Caffrey CR
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6063-73. PubMed ID: 24060869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
    Manjunatha UH; Chao AT; Leong FJ; Diagana TT
    ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.